Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
RESEARCH TOOLSreports
Holding MDGL?
Track your performance easily
See the Price Targets and Ratings of:
MDGL Analyst Ratings
Strong Buy
10 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDGL Stock 12 Month Forecast
Average Price Target
$377.45
▲(8.63% Upside)
| Highest Price Target$441.00 | Average Price Target$377.45 | Lowest Price Target$236.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Assigned
11/20/24
Oppenheimer
Reiterated
11/20/24
B.Riley Financial
Reiterated
11/05/24
Jefferies
Reiterated
11/04/24
Evercore ISI
Assigned
11/01/24
Bank of America Securities
Assigned
11/01/24
Leerink Partners
Reiterated
10/31/24
Canaccord Genuity
Reiterated
10/31/24
H.C. Wainwright
Reiterated
10/22/24
Piper Sandler
$336
Buy
-3.30%
Downside
Assigned
10/08/24
Piper Sandler Sticks to Their Buy Rating for Madrigal Pharmaceuticals (MDGL)
JMP Securities
$415
Buy
19.44%
Upside
Reiterated
10/07/24
Buy Rating on Madrigal Pharmaceuticals: Rezdiffra's Rising Prescription Rates and Blockbuster Potential Drive Positive Outlook
Citi
$382→$371
Buy
6.78%
Upside
Reiterated
08/08/24
Madrigal Pharmaceuticals price target lowered to $371 from $382 at CitiMadrigal Pharmaceuticals price target lowered to $371 from $382 at Citi
Wolfe Research
$150
Sell
-56.83%
Downside
Reiterated
08/07/24
Underperform Rating on Madrigal Pharmaceuticals Amid Rezdiffra's Commercial and Competitive Challenges
Best Analysts Covering Madrigal Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy MDGL and Sell After:
1 Month
xxx
Success Rate
12/21 ratings generated profit
Average Return
+11.00%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +11.00% per trade.
3 Months
xxx
Success Rate
11/14 ratings generated profit
Average Return
+14.06%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 78.57% of your transactions generating a profit, with an average return of +14.06% per trade.
1 Year
Success Rate
15/21 ratings generated profit
Average Return
+95.05%
reiterated a buy rating 23 days ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +95.05% per trade.
2 Years
xxx
Success Rate
21/21 ratings generated profit
Average Return
+125.99%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +125.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDGL Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Oct 24
Nov 24
Strong Buy
16
15
12
17
16
Buy
2
3
4
3
8
Hold
3
4
4
2
2
Sell
2
1
1
2
3
Strong Sell
0
0
0
0
0
total
23
23
21
24
29
Each month's total comprises the sum of three months' worth of ratings.
MDGL Financial Forecast
MDGL Stock Forecast FAQ
What is MDGL’s average 12-month price target, according to analysts?
Based on analyst ratings, Madrigal Pharmaceuticals Inc’s 12-month average price target is $377.45.
What is MDGL’s upside potential, based on the analysts’ average price target?
Madrigal Pharmaceuticals Inc has 8.63% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MDGL a Buy, Sell or Hold?
Madrigal Pharmaceuticals Inc has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 1 sell ratings.
What is Madrigal Pharmaceuticals Inc’s price target?
The average price target for Madrigal Pharmaceuticals Inc is $377.45. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $441.00 ,the lowest forecast is $236.00. The average price target represents 8.63% Increase from the current price of $347.45.
The highest analyst price target is $441.00 ,the lowest forecast is $236.00. The average price target represents 8.63% Increase from the current price of $347.45.
What do analysts say about Madrigal Pharmaceuticals Inc?
Madrigal Pharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of MDGL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.